Tag Archives: DDMAC

Building a Better Brief Summary

Image via Wikipedia FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising. Surprise, people tend to absorb far less information from the giant blocks of text printed in drab language. DDMAC social science analyst Amy O’Donoghue explained FDA’s recent study results to an audience […]
Posted in Advertising, Regulatory | Also tagged , , , , | 4 Comments

Live from DIA: FDA Warning Letters Stir More Questions Than Answers

A panel of regulators from FDA’s Division of Drug Marketing, Advertising, and Communications were taken to task, this morning at the Drug Information Association’s annual meeting, for 14 warning letters levied on drug companies for not including risk information in online search ads. A Sanofi Aventis employee complained about the 14 warning letters and asked […]
Posted in Advertising, Regulatory | Also tagged , , , , , | 2 Comments

The Regulation Wars

Last Friday, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) issued 14 untitled letters to pharma companies as a result of online advertisements that appeared as sponsored links on search engine results pages. There were already plenty of guidelines on marketing to consumers being enforced by PhRMA, but now comes a crackdown on Internet […]
Posted in Marketing, Regulatory | Also tagged , | 2 Comments

Is FDA Watching YouTube?

Two weeks ago, Shire received a warning letter for posting a sponsored testimonial on YouTube without including risk information. Shire was very open when I called them up and admitted that the video was posted by accident and immediately removed when it was brought to the company’s attention. While I’m not 100 percent positive, it […]
Posted in E-Media, Marketing, Regulatory | Also tagged , , , , , , , | 6 Comments
  • Categories

  • Meta